Ivan Griffin makes and manages investments in the Healthcare sector. He serves as a COO and Co-Founder of benevolent.ai that was founded in 2013 by the management team of Proximagen. The company’s focus at present is to bring together artificial intelligence technology and scientific research to enable the creation of better medicines for some of humanity's most debilitating diseases